Drug maker Wockhardt's two promoter group firms, including Khorakiwala Holdings and Investments, have revoked 53 lakh shares pledged with the lenders, reducing their combined stake of pledged shares to 52.89 per cent.
In a regulatory disclosure to the Bombay Stock Exchange, Wockhardt today said its promoter Khorakiwala Holdings and Investments has revoked 11.47 lakh shares on June 22, after which the entity's pledged stake in the drug company stands at 52.89 per cent.
Meanwhile, another promoter Dartmour Holdings also revoked 41.53 lakh shares on the same day. Post transaction, Dartmour Holdings' pledged stake in the company now stands nil.
At the end of March quarter, Khorakiwala Holdings & Investments held a 63.70 per cent stake in the pharmaceuticals firm, whereas Dartmour Holdings held a 6.24 per cent stake in the company.
Shares of Wockhardt were trading at Rs 126.30, up 6 per cent in the afternoon trade on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
